Nonalcoholic Fatty Liver Disease after Liver Transplant

被引：14

作者：

Shetty, Akshay ^{[1
]}

Giron, Fanny ^{[2
]}

Divatia, Mukul K. ^{[3
]}

Ahmad, Muhammad, I ^{[1
]}

Kodali, Sudha ^{[1
]}

Victor, David ^{[1
]}

机构：

[1] Houston Methodist Hosp, Sherrie & Alan Conover Ctr Liver Dis & Transplant, Dept Med, Outpatient Ctr 22nd Floor, Houston, TX 77030 USA

[2] Houston Methodist Hosp, Dept Med, Houston, TX 77030 USA

[3] Houston Methodist Hosp, Weill Cornell Med Coll, Dept Pathol & Genom Med, Houston, TX 77030 USA

来源：

JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY | 2021年 / 9卷 / 03期

关键词：

Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Post-transplant; Recurrent NAFLD; De novo NAFLD; Recurrent NASH; De novo NASH; CRYPTOGENIC CIRRHOSIS; AMERICAN ASSOCIATION; BARIATRIC SURGERY; NATURAL-HISTORY; SCORING SYSTEM; STEATOHEPATITIS; PREVALENCE; RECIPIENTS; RECURRENCE; EPIDEMIOLOGY;

D O I：

10.14218/JCTH.2020.00072

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Nonalcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver disease in the world. The rising prevalence of nonalcoholic steatohepatitis (NASH) has led to a 170% increase in NASH cirrhosis as the listing indication for liver transplantation from 2004 to 2013. As of 2018, NASH has overtaken hepatitis C as an indication for liver transplantation in the USA. After liver transplantation, the allograft often develops recurrent NAFLD among patients with known NASH cirrhosis. In addition to recurrent disease, de novo NAFLD has been reported in patients with other indications for liver transplantation. In this review, we will discuss the risk factors associated with recurrent and de novo NAFLD, natural course of the disease, and management strategies after liver transplantation.

引用

页码：428 / 435

页数：8

共 50 条

[1] Nonalcoholic Fatty Liver Disease After Liver Transplantation for Cryptogenic Cirrhosis or Nonalcoholic Fatty Liver Disease
Yalamanchili, Kanthi
Saadeh, Sherif
Klintmalm, Goeran B.
Jennings, Linda W.
Davis, Gary L.
[J]. LIVER TRANSPLANTATION, 2010, 16 (04) : 431 - 439
[2] Nonalcoholic Fatty Liver Disease in the Post Liver Transplant Patient
Batisti, Jennifer
Mehal, Wajahat Z.
[J]. CURRENT TRANSPLANTATION REPORTS, 2020, 7 (04) : 332 - 339
[3] Nonalcoholic Fatty Liver Disease in the Post Liver Transplant Patient
Jennifer Batisti
Wajahat Z. Mehal
[J]. Current Transplantation Reports, 2020, 7 : 332 - 339
[4] Peri-transplant management of nonalcoholic fatty liver disease in liver transplant candidates
Samji, Naga Swetha
Heda, Rajiv
Satapathy, Sanjaya K.
[J]. TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 5
[5] Nonalcoholic Fatty Liver Disease After Pancreaticoduodenectomy
Mavromates, Spiro
Perry, Isaac
Hannah, William
Carpenter, Steven
[J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S1346 - S1346
[6] Prevalence and Impact of Fatty Liver Disease in Adult Deceased Liver Transplant Donors: Metabolic-Associated Fatty Liver Disease or Nonalcoholic Fatty Liver Disease?
Liu, Ken
Pandya, Keval
West, Claire
Virtue, Susan
McCaughan, Geoffrey W.
[J]. LIVER TRANSPLANTATION, 2021, 27 (10) : 1498 - 1501
[7] Evolution of nonalcoholic fatty liver disease recurrence after liver transplantation
Patil, Deepa T.
Yerian, Lisa M.
[J]. LIVER TRANSPLANTATION, 2012, 18 (10) : 1147 - 1153
[8] Preventive Strategies for Nonalcoholic Fatty Liver Disease After Liver Transplantation
Choudhary, Narendra S.
Saigal, Sanjiv
[J]. JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2019, 9 (05) : 619 - 624
[9] de novo nonalcoholic fatty liver disease after liver transplantation
Abdelmalek, Manal F.
Diehl, Anna Mae
[J]. LIVER TRANSPLANTATION, 2007, 13 (06) : 788 - 790
[10] Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis in Liver Transplantation
Carter, Danielle
Dieterich, Douglas T.
Chang, Charissa
[J]. CLINICS IN LIVER DISEASE, 2018, 22 (01) : 213 - +

← 1 2 3 4 5 →